Medicinal products

Overview of the proposed reform of EU pharmaceutical legislation: its objectives, key changes and expected impact on patients and industry.

EU proposal to strengthen availability and supply of critical medicines, tackle shortages and boost resilience of essential medicine supply chains.

Overview of clinical trials in the EU: their purpose, how they are authorised and conducted, and the regulatory framework.

EU efforts to advance biotechnology, boost innovation and strengthen competitiveness in health and industry across the EU.

Information on risks from falsified medicines and EU measures to prevent and control fake products entering the supply chain.

Overview of EU requirements for good manufacturing and distribution practices to ensure quality of medicines and active substances.

The EU body of pharmaceutical law and supporting guidelines that govern medicinal products and their regulatory framework.